Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological Malignancies

NCT05457595 is registered in ClinicalTrials.gov with CNAO National Center of Oncological Hadrontherapy as lead sponsor.

NCT NCT05457595
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05457595 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological Malignancies
Lead sponsor
CNAO National Center of Oncological Hadrontherapy
Phase
Not applicable
Overall status
Recruiting
Start date
February 24, 2021
Completion date
February 25, 2028
Enrollment
55 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant epithelial neoplasm, malignant epithelial neoplasm of vulva, malignant epithelial tumor of ovary, tumor recurrence